Full Text
The Impact of Disease Modification on the Cost-Effectiveness of Pegloticase for the Treatment of Severe Debilitating Chronic Tophaceous Gout In Adult Patients

Abstract

Authors

K. Wallerstein K. Tolley S. Vegter

Back to Volume 17, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×